(1->4)-beta-D-glucan multiple interactions ISO RGD:1313815 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R5E mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:1313815 6480464 1, 2-Dimethylhydrazine results in decreased expression of PPP2R5E mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1313815 6480464 Ethinyl Estradiol affects the expression of PPP2R5E mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1313815 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R5E mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1313815 6480464 Ethinyl Estradiol results in increased expression of PPP2R5E mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1313815 6480464 Ethinyl Estradiol results in decreased expression of PPP2R5E mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1313814 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313815 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R5E mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313815 6480464 Tetrachlorodibenzodioxin affects the expression of PPP2R5E mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313815 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP2R5E mRNA CTD PMID:23994337 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP2R5E mRNA CTD PMID:21215274 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PPP2R5E mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1313815 6480464 3 more ... CTD PMID:23994337 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1313815 6480464 3 more ... CTD PMID:19467301 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1313814 6480464 tetrabromobisphenol A results in decreased expression of PPP2R5E protein CTD PMID:31675489 Aflatoxin B2 alpha decreases methylation ISO RGD:1313814 6480464 aflatoxin B2 results in decreased methylation of PPP2R5E intron CTD PMID:30157460 antirheumatic drug increases expression ISO RGD:1313814 6480464 Antirheumatic Agents results in increased expression of PPP2R5E mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1313814 6480464 aristolochic acid I results in decreased expression of PPP2R5E mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1313814 6480464 arsenite promotes the reaction [G3BP1 protein binds to PPP2R5E mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:1313814 6480464 Atrazine results in decreased expression of PPP2R5E mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1313815 6480464 Benzo(a)pyrene results in decreased expression of PPP2R5E mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1313814 6480464 Benzo(a)pyrene affects the methylation of PPP2R5E intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1313815 6480464 Benzo(a)pyrene results in increased expression of PPP2R5E mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1313814 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 benzo[e]pyrene decreases methylation ISO RGD:1313814 6480464 benzo(e)pyrene results in decreased methylation of PPP2R5E intron CTD PMID:30157460 beta-naphthoflavone increases expression ISO RGD:1313815 6480464 beta-Naphthoflavone results in increased expression of PPP2R5E mRNA CTD PMID:23994337 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PPP2R5E mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1313814 6480464 bisphenol A results in decreased methylation of PPP2R5E gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1313814 6480464 bisphenol A results in decreased expression of PPP2R5E protein CTD PMID:31675489 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PPP2R5E gene CTD PMID:28505145 caffeine decreases phosphorylation ISO RGD:1313814 6480464 Caffeine results in decreased phosphorylation of PPP2R5E protein CTD PMID:35688186 camptothecin multiple interactions ISO RGD:1313814 6480464 Camptothecin affects the localization of [PPP2R5E protein binds to PPP2CA protein], PPP2R5E protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form] CTD PMID:25772433 camptothecin decreases response to substance ISO RGD:1313814 6480464 PPP2R5E protein results in decreased susceptibility to Camptothecin CTD PMID:25772433 carbon nanotube increases expression ISO RGD:1313815 6480464 Nanotubes, Carbon results in increased expression of PPP2R5E mRNA CTD PMID:25620056 choline multiple interactions ISO RGD:1313815 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:1313815 6480464 Ciguatoxins affects the expression of PPP2R5E mRNA CTD PMID:18353800 copper(II) sulfate increases expression ISO RGD:1313814 6480464 Copper Sulfate results in increased expression of PPP2R5E mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:1313814 6480464 coumarin results in decreased phosphorylation of PPP2R5E protein CTD PMID:35688186 coumestrol decreases expression ISO RGD:1313814 6480464 Coumestrol results in decreased expression of PPP2R5E mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1313815 6480464 Cyclosporine results in decreased expression of PPP2R5E mRNA CTD PMID:19770486 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of PPP2R5E mRNA CTD PMID:23640034 dimethylarsinous acid decreases expression ISO RGD:1313814 6480464 dimethylarsinous acid results in decreased expression of PPP2R5E mRNA CTD PMID:23487506 disodium selenite increases expression ISO RGD:1313814 6480464 Sodium Selenite results in increased expression of PPP2R5E mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1313814 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1313814 6480464 Doxorubicin results in decreased expression of PPP2R5E mRNA CTD PMID:29803840 Echimidine multiple interactions ISO RGD:1313814 6480464 [CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PPP2R5E mRNA CTD PMID:33884520 elemental selenium decreases expression ISO RGD:1313814 6480464 Selenium results in decreased expression of PPP2R5E mRNA CTD PMID:19244175 fenthion decreases expression ISO RGD:1313815 6480464 Fenthion results in decreased expression of PPP2R5E mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:1313815 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1313814 6480464 Formaldehyde results in decreased expression of PPP2R5E mRNA CTD PMID:23649840 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of PPP2R5E mRNA CTD PMID:24136188 gold atom multiple interactions ISO RGD:1313815 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA CTD PMID:19695318 gold(0) multiple interactions ISO RGD:1313815 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA CTD PMID:19695318 inulin multiple interactions ISO RGD:1313815 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP2R5E mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:1313814 6480464 Ivermectin results in decreased expression of PPP2R5E protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1313815 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene CTD PMID:20938992 methapyrilene decreases methylation ISO RGD:1313814 6480464 Methapyrilene results in decreased methylation of PPP2R5E intron CTD PMID:30157460 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PPP2R5E mRNA CTD PMID:30467583 methidathion decreases expression ISO RGD:1313815 6480464 methidathion results in decreased expression of PPP2R5E mRNA CTD PMID:34813904 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of PPP2R5E gene CTD PMID:35440735 mitomycin C decreases response to substance ISO RGD:1313814 6480464 PPP2R5E protein results in decreased susceptibility to Mitomycin CTD PMID:25772433 monocrotaline multiple interactions ISO RGD:1313814 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in increased expression of PPP2R5E mRNA CTD PMID:33884520 N-methyl-N'-nitro-N-nitrosoguanidine decreases response to substance ISO RGD:1313814 6480464 PPP2R5E protein results in decreased susceptibility to Methylnitronitrosoguanidine CTD PMID:25772433 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PPP2R5E mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPP2R5E mRNA CTD PMID:25729387 paracetamol decreases expression ISO RGD:1313814 6480464 Acetaminophen results in decreased expression of PPP2R5E mRNA CTD PMID:21420995 pentachlorophenol affects expression ISO RGD:1313815 6480464 Pentachlorophenol affects the expression of PPP2R5E mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1313815 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R5E mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP2R5E mRNA CTD PMID:36331819 phenobarbital decreases expression ISO RGD:1313815 6480464 Phenobarbital results in decreased expression of PPP2R5E mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1313814 6480464 Phenylmercuric Acetate results in decreased expression of PPP2R5E mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1313814 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1313815 6480464 pirinixic acid results in decreased expression of PPP2R5E mRNA CTD PMID:23811191 SB 431542 multiple interactions ISO RGD:1313814 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:1313814 6480464 Selenium results in decreased expression of PPP2R5E mRNA CTD PMID:19244175 tamoxifen affects expression ISO RGD:1313815 6480464 Tamoxifen affects the expression of PPP2R5E mRNA CTD PMID:17555576 taurine decreases expression ISO RGD:1313814 6480464 Taurine results in decreased expression of PPP2R5E mRNA CTD PMID:16579726 toluene affects expression EXP 6480464 Toluene affects the expression of PPP2R5E mRNA CTD PMID:21827849 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PPP2R5E mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPP2R5E mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of PPP2R5E gene CTD PMID:27618143 triptonide increases expression ISO RGD:1313815 6480464 triptonide results in increased expression of PPP2R5E mRNA CTD PMID:33045310 tunicamycin increases expression ISO RGD:1313815 6480464 Tunicamycin results in increased expression of PPP2R5E mRNA CTD PMID:17127020 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PPP2R5E mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1313815 6480464 Valproic Acid affects the expression of PPP2R5E mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1313814 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1313814 6480464 Valproic Acid results in decreased expression of PPP2R5E mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PPP2R5E mRNA CTD PMID:19015723
